Literature DB >> 15239484

Epidemiology and burden of cardiovascular disease.

Laurence O Watkins1.   

Abstract

Coronary heart disease (CHD) is the leading cause of death in the United States. The rate of CHD and CHD death varies across racial groups, with higher rates among black men and women than among white men and women. The development of CHD is promoted by major CHD risk factors--dyslipidemia, hypertension, and smoking. These risk factors are independently associated with CHD risk and are common among adults in the United States. Diabetes mellitus is also a significant contributor to CHD risk and is associated with risk of a CHD event equivalent to that conferred by the presence of prior CHD. Metabolic syndrome, a related condition, also confers a high risk for CHD as well as for the development of type 2 diabetes. Diabetes and metabolic syndrome are characterized by the presence of central obesity and insulin resistance, which result in dyslipidemia, hypertension, and cardiovascular derangements that promote CHD. Diabetes and metabolic syndrome illustrate the significance of risk factor clustering, which contributes to CHD risk through the additive effect of each risk factor. Diabetes, metabolic syndrome, and risk factor clustering in general are becoming more prevalent, which illustrates the need for better CHD prevention strategies aimed at risk factor control. The pathologic process associated with risk factor clustering also contributes to the higher CHD burden among black men and women, who have a higher prevalence of risk factor clustering and type 2 diabetes. Furthermore, despite having a higher CHD risk, black men and women are less likely to receive adequate treatment or control of risk factors, including dyslipidemia or hypertension. Eliminating disparities among population groups will thus require aggressive efforts focused on risk assessment, guideline adherence, and risk factor control in populations in need.

Entities:  

Mesh:

Year:  2004        PMID: 15239484      PMCID: PMC6654722          DOI: 10.1002/clc.4960271503

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  31 in total

1.  Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey.

Authors:  Karin Nelson; Keith Norris; Carol M Mangione
Journal:  Arch Intern Med       Date:  2002-04-22

2.  Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease.

Authors:  Gerald Reaven
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

3.  Obesity, metabolic syndrome, and coronary atherosclerosis.

Authors:  Scott M Grundy
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

4.  Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

Authors:  F L Brancati; W H Kao; A R Folsom; R L Watson; M Szklo
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

5.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

6.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

7.  Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997.

Authors:  Daniel W Jones; Lloyd E Chambless; Aaron R Folsom; Gerardo Heiss; Richard G Hutchinson; A Richey Sharrett; Moyses Szklo; Herman A Taylor
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

8.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors:  R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

9.  Representation of blacks, women, and the very elderly (aged > or = 80) in 28 major randomized clinical trials.

Authors:  W D Hall
Journal:  Ethn Dis       Date:  1999       Impact factor: 1.847

10.  Prevalence and trends in obesity among US adults, 1999-2000.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

View more
  23 in total

1.  Gene expression profiling of coronary artery disease and its relation with different severities.

Authors:  Shiridhar Kashyap; Sudeep Kumar; Vikas Agarwal; Durga P Misra; Shubha R Phadke; Aditya Kapoor
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

2.  Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Authors:  Richard E Kennedy; Gary R Cutter; Guoqiao Wang; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-25       Impact factor: 4.105

3.  Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; Beeya Na; Nelson B Schiller; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-30       Impact factor: 5.162

4.  Antisocial behavioral syndromes and past-year physical health among adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Risë B Goldstein; Deborah A Dawson; S Patricia Chou; W June Ruan; Tulshi D Saha; Roger P Pickering; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

5.  Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.

Authors:  Yongjun Liu; Jose M Ordovas; Guimin Gao; Michael Province; Robert J Straka; Michael Y Tsai; Chao-Qiang Lai; Kui Zhang; Ingrid Borecki; James E Hixson; David B Allison; Donna K Arnett
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

6.  Cardiopulmonary resuscitation among mechanically ventilated patients.

Authors:  Ali Al-Alwan; William J Ehlenbach; Prema R Menon; Michael P Young; Renee D Stapleton
Journal:  Intensive Care Med       Date:  2014-02-26       Impact factor: 17.440

7.  Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly.

Authors:  William J Ehlenbach; Amber E Barnato; J Randall Curtis; William Kreuter; Thomas D Koepsell; Richard A Deyo; Renee D Stapleton
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  Racial Differences in the Association Between Apolipoprotein E Risk Alleles and Overall and Total Cardiovascular Mortality Over 18 Years.

Authors:  Kumar B Rajan; Lisa L Barnes; Robert S Wilson; Elizabeth A McAninch; Jennifer Weuve; Dominique Sighoko; Denis A Evans
Journal:  J Am Geriatr Soc       Date:  2017-09-12       Impact factor: 5.562

9.  Multiple in-hospital resuscitation efforts in the elderly.

Authors:  Prema R Menon; William J Ehlenbach; Dee W Ford; Renee D Stapleton
Journal:  Crit Care Med       Date:  2014-01       Impact factor: 7.598

10.  The in vivo cardiac kinetics of Tc-99m N-NOET are accelerated in obese, hyperlipidemic Zucker rats.

Authors:  Laurent M Riou; Alexis Broisat; Julien Dimastromatteo; Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.